Majority of Pregnant Women Who Tested Positive for COVID-19 Were Asymptomatic, Study Finds
The majority of pregnant women who tested positive for COVID-19 on arrival to the delivery room were asymptomatic, according to a paper by Mount Sinai researchers published in PLOS One on Thursday, December 10. The pregnant patients who tested positive for the coronavirus were also more likely than those who tested negative to identify as Hispanic and report their primary language as Spanish.
In a retrospective cross-sectional study of universal screenings for SARS-Cov-2, the virus that causes COVID-19, implemented in the labor and delivery unit of Elmhurst Hospital in Queens, New York, during March and April, the researchers found that more than one-third of almost 130 pregnant women tested positive for the coronavirus. This is a much higher proportion than reported at other hospitals in New York City during the pandemic surge, and likely related to social inequities experienced by the surrounding population. Elmhurst Hospital is a public hospital that serves a diverse, largely immigrant and low-income patient population that was severely affected by the COVID-19 pandemic in the spring. The majority, or 72 percent, of the pregnant patients who tested positive were asymptomatic, meaning they did not display any symptoms associated with COVID-19. These findings add to the evidence that there was early and rampant asymptomatic spread of the disease at a time when most community and hospital testing was limited to symptomatic individuals.
“This study is instructive for other labor and delivery units and hospitals across the world as we continue to refine pandemic preparedness,” says Sheela Maru, MD, MPH, Assistant Professor of Global Health, and Obstetrics, Gynecology and Reproductive Science, at the Icahn School of Medicine at Mount Sinai. “In future epidemics, it may be prudent to look at labor and delivery screening numbers much earlier on, as pregnant women continue to seek essential care despite social distancing measures and also represent the general young and healthy community population.”
Dr. Maru said universal screening in the labor and delivery unit ensured safety of patients and staff during an acute surge in COVID-19 infections through appropriate identification and isolation of pregnant women with positive test results. Women were roomed by their status and were provided postpartum counseling and follow-up protocols tailored to their specific social needs.
In addition to their status for COVID-19, the study reviewed patients’ demographic data including age, ethnicity, primary language, zip code, marital status, and health insurance status, and clinical data including the mode of delivery, length of stay, and comorbidities such as chronic hypertension, preeclampsia, prepregnancy obesity, asthma, diabetes, depression, and anxiety.
The study was developed through participation in the COVID-19 Unit for Research at Elmhurst (CURE-19) partnership, an initiative by Mount Sinai’s Arnhold Institute for Global Health and NYC Health + Hospitals/Elmhurst to research the global pandemic and root causes of health disparities in New York City.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.